Mizuhiko Terasaki - Concepedia

Author

Mizuhiko Terasaki

Kurume University

Also Known As

I. Dunkel, M Terasaki, M. Terasaki, MIZUHIKO TERASAKI, Miya Terasaki, Mizuhiko TERASAKI, Mizuhiko Terasaki

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

Kurume University Tohoku University Saitama Medical University Hiroshima University Children's Cancer Association of Japan

About

Mizuhiko Terasaki is an author at Kurume University specializing in medicine, neuro-oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	5.5K
2	Health Sciences	5	5	5.1K
3	Cell Biology	5	5	5K
4	Allergy	1	1	24
5	Cellular Physiology	1	1	11

Mizuhiko Terasaki

Publications

Citations

H-Index

Page 1

	Year	Citations
Identification of a cancer stem cell in human brain tumors. Sheila K. Singh, Ian D. Clarke, Mizuhiko Terasaki, PubMed Tumor InnervationCancer Stem CellPathologyStem Cell BiologyGlioma	2003	4.9K
Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial Takamasa Kayama, Shinya Sato, Kaori Sakurada, Journal of Clinical Oncology Surgical OncologyNeuropsychologyWbrt ArmInterdisciplinary NeurosurgerySurgery	2018	180
Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen–A24 With Recurrent or Progressive Glioblastoma Multiforme Mizuhiko Terasaki, Soichiro Shibui, Yoshitaka Narita, Journal of Clinical Oncology	2010	121
A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma Yoshitaka Narita, Yoshiki Arakawa, Fumiyuki Yamasaki, Neuro-Oncology	2018	95
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma Toshihiko Wakabayashi, Atsushi Natsume, Junki Mizusawa, Journal of Neuro-Oncology	2018	63
Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases Shintaro Fukushima, Mizuhiko Terasaki, Kiyohiko Sakata, Brain Tumor Pathology Meningioma CasesMitotic FiguresImmunologyPathologyMedicine	2009	60
A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis† Motomasa Furuse, Naosuke Nonoguchi, Toshihiko Kuroiwa, Neuro-Oncology Practice	2016	56
Acute focal demyelinating disease simulating brain tumors: Histopathologic guidelines for an accurate diagnosis Yasuo Sugita, Mizuhiko Terasaki, Minoru Shigemori, Neuropathology Neurological DisorderWhite MatterPathologyBrain LesionHistopathologic Guidelines	2001	39
A pilot study of hypofractionated radiation therapy with temozolomide for adults with glioblastoma multiforme Mizuhiko Terasaki, Tomoko Eto, Shinji Nakashima, Journal of Neuro-Oncology Neuro-oncologyHealth SciencesRadiation TherapyGlioblastoma MultiformeMedicine	2010	35
Fibroblast growth factor-2 and -9 regulate proliferation and production of matrix metalloproteinases in human gliomas. Naohisa Miyagi, Seiya Kato, Mizuhiko Terasaki, International Journal of Oncology Mmp-2 ExpressionPathologyFibroblast Growth Factor-2GliomaCancer Biology	1998	30

Page 1